Portal de Periódicos da CAPES

Comparative Effectiveness Trial for Diabetic Macular Edema

2015; American Medical Association; Volume: 133; Issue: 9 Linguagem: Inglês

10.1001/jamaophthalmol.2015.1880

2168-6173

Lee M. Jampol, Adam R. Glassman, Neil M. Bressler,

Retinal and Optic Conditions

This Viewpoint discusses the early findings of the Diabetic Retinopathy Clinical Research Network, which is comparing the effectiveness of aflibercept, bevacizumab, and ranibizumab in patients with diabetic macular edema.